Symptomatic treatment of nasal and ocular symptoms of seasonal and year-round allergic rhinitis, chronic idiopathic urticaria.
Composition and form of release
Available as 10 mg tablets.
The active substance of the drug is cetirizine dihydrochloride.
Rolinoz is an anti-allergic medicine. Its active substance is a blocker of H1-histamine receptors.
This medication is prescribed to eliminate nasal (nasal), eye symptoms of persistent (year-round) or intermittent (seasonal) allergic rhinitis, allergic conjunctivitis (nasal congestion, conjunctival redness, itching in the nose / eyes, sneezing, watery eyes). It can also be used for chronic idiopathic urticaria.
You cannot appoint Rolinoz:
- with allergies to components;
- at the terminal stage of renal failure (with an indicator of creatinine clearance;
- during pregnancy;
- for tablets: with rare forms of galactose intolerance, Lapp lactase deficiency, glucose / galactose malabsorption.
It is used with caution:
- with old age;
- with a predisposition to urinary retention;
- with chronic kidney disease (with a creatinine clearance rate> 10 ml / minute) – dosage adjustment is required;
- with epilepsy, increased convulsive readiness;
- during lactation.
Application during pregnancy and lactation
No cases of the formation of malformations, embryonic, neonatal toxicity with a clear causal relationship have been identified. However, there have been no strictly controlled studies, therefore this medication should not be used during pregnancy.
The medicine can penetrate into breast milk, therefore, feeding is stopped during treatment.
Method of administration and dosage
It is administered orally (by mouth), regardless of food.
Children aged 2–6 years: the medicine is used in the form of drops of 2.5 mg (5 drops) x2 times / day.
Adults, children over 6 years of age: daily dose – 10 mg (20 drops or 1 tablet) once (preferably at night).
An initial dose of 5 mg (10 drops or half a tablet) can be used if sufficient to control symptoms.
Overdose symptoms: confusion, increased fatigue, diarrhea, dizziness, headache, itching, malaise, dilated pupils, anxiety, drowsiness, weakness, stupor, frequent heartbeat, tremors, urinary retention.
Overdose treatment: immediately after administration – gastric lavage (or stimulation of vomiting), intake of sorbent (activated carbon), maintenance and symptomatic therapy.
Possible allergic reactions (angioedema, urticaria, rash, itching, persistent drug erythema), increased appetite, thrombocytopenia (decreased platelet count), agitation, confusion, depression, aggression, hallucinations, sleep disturbances, nervous tics, suicidal ideation, movement disorders , paresthesia, convulsions, taste perversion, fainting, trembling, memory impairment, impaired accommodation, nystagmus (wobbling of the eyes), blurred vision, dizziness, heart palpitations, loose stools, liver dysfunctions, changes in liver function tests, urinary disturbances (urinary retention, enuresis ), malaise, swelling, weight gain.
Storage conditions and periods
The Rolinoz preparation must be stored in its original packaging in compliance with the temperature regime (within 15-25 ° C), low humidity, and no direct sunlight. The maximum shelf life of the medicine is indicated on the package (three years). After the first use, the drops must be used within 21 months.
Parents need to keep their children safe and restrict their access to medication.